FDA ap­proves Re­by­ota, Fer­ring's poop-based drug to fight C. diff in­fec­tion

The FDA ap­proved Fer­ring Phar­ma­ceu­ti­cals’ Re­by­ota drug on Wednes­day, a poop-based drug im­plant that can pre­vent the re­cur­rence of Clostrid­ioides dif­fi­cile in­fec­tion.

While the use …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER